An amendment numbered 11 printed in House Report 109-387 to direct the ONDCP to request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress on the study.
What it does: Adds SEC. 20. STUDY ON PRESCRIPTION DRUGS ASSOCIATED WITH IATROGENIC ADDICTION at the end of the bill
Rep. Stephen F. Lynch (D-MA)Description
Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.
What it changes
1 change to H.R. 2829
We couldn't match these changes to the text of H.R. 2829, so they're shown as written.
Adds SEC. 20. STUDY ON PRESCRIPTION DRUGS ASSOCIATED WITH IATROGENIC ADDICTION at the end of the bill
Adds a sectionInserted: SEC. 20. STUDY ON PRESCRIPTION DRUGS ASSOCIATED WITH IATROGENIC ADDICTION.
Inserted: (a) In General.--The Director of the Office of National Drug Control Policy shall request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study examining certain aspects of prescription drugs associated with iatrogenic addiction, including oxycodone hydrochloride controlled-release tablets.
Inserted: (b) Requirements.--The study conducted pursuant to this section shall evaluate--
Inserted: (1) the rate and impact of iatrogenic addiction associated with the use of prescription drugs described in subsection (a); and
Inserted: (2) the relative addictiveness of prescription drugs described in subsection (a) when compared with other opioids and other substances included in schedule I or II of the schedules of controlled substances established by section 202 of the Controlled Substances Act (21 U.S.C. 812).
Inserted: (c) Report.--The Director of the Office of National Drug Control Policy shall ensure that the agreement under subsection (a) provides for the submission of a report to the Congress, not later than one year after the date of the enactment of this Act, on the results of the study conducted pursuant to this section.
Original wording
At the end of the bill, add the following (and make such conforming changes as may be necessary to the table of contents):
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
At the end of the bill, add the following (and make such conforming changes as may be necessary to the table of contents):
SEC. 20. STUDY ON PRESCRIPTION DRUGS ASSOCIATED WITH IATROGENIC ADDICTION.
(a) In General.--The Director of the Office of National Drug Control Policy shall request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study examining certain aspects of prescription drugs associated with iatrogenic addiction, including oxycodone hydrochloride controlled-release tablets.
(b) Requirements.--The study conducted pursuant to this section shall evaluate--
(1) the rate and impact of iatrogenic addiction associated with the use of prescription drugs described in subsection (a); and
(2) the relative addictiveness of prescription drugs described in subsection (a) when compared with other opioids and other substances included in schedule I or II of the schedules of controlled substances established by section 202 of the Controlled Substances Act (21 U.S.C. 812).
(c) Report.--The Director of the Office of National Drug Control Policy shall ensure that the agreement under subsection (a) provides for the submission of a report to the Congress, not later than one year after the date of the enactment of this Act, on the results of the study conducted pursuant to this section.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
House amendment offered
March 9, 2006
View full timeline
House amendment offered
March 9, 2006
House amendment agreed to: On agreeing to the Lynch amendment (A011) Agreed to by voice vote.
March 9, 2006 • 2:02 PM
Amendment agreed to Committee of the Whole
March 9, 2006 • 2:02 PM
House amendment offered/reported by : Amendment (A011) offered by Mr. Lynch.(consideration: CR H834-835; text: CR H834)
March 9, 2006 • 1:51 PM
Amendment (A011) offered by Mr. Lynch. (consideration: CR H834-835; text: CR H834)
March 9, 2006 • 1:51 PM
On agreeing to the Lynch amendment (A011) Agreed to by voice vote.
March 9, 2006 • 2:02 PM